Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice
- PMID: 39122688
- PMCID: PMC11315933
- DOI: 10.1038/s41467-024-51182-3
Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice
Abstract
Influenza virus infection remains a major global health problem and requires a universal vaccine with broad protection against different subtypes as well as a rapid-response vaccine to provide immediate protection in the event of an epidemic outbreak. Here, we show that intranasal administration of probiotic Escherichia coli Nissle 1917 activates innate immunity in the respiratory tract and provides immediate protection against influenza virus infection within 1 day. Based on this vehicle, a recombinant strain is engineered to express and secret five tandem repeats of the extracellular domain of matrix protein 2 from different influenza virus subtypes. Intranasal vaccination with this strain induces durable humoral and mucosal responses in the respiratory tract, and provides broad protection against the lethal challenge of divergent influenza viruses in female BALB/c mice. Our findings highlight a promising delivery platform for developing mucosal vaccines that provide immediate and sustained protection against respiratory pathogens.
© 2024. The Author(s).
Conflict of interest statement
Ling H., W.T., S.C., and Y.H. have filed patents related to the EcN-5M2e vaccine described in this manuscript. The remaining authors declare no competing interests.
Figures
Similar articles
-
Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.J Virol. 2014 Sep 1;88(17):9693-703. doi: 10.1128/JVI.00823-14. Epub 2014 Jun 11. J Virol. 2014. PMID: 24920793 Free PMC article.
-
Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice.Virol J. 2014 Feb 6;11:21. doi: 10.1186/1743-422X-11-21. Virol J. 2014. PMID: 24502341 Free PMC article.
-
Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes.Vet Microbiol. 2017 Mar;201:240-251. doi: 10.1016/j.vetmic.2017.01.020. Epub 2017 Jan 21. Vet Microbiol. 2017. PMID: 28284616
-
In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.Virology. 2012 Aug 15;430(1):63-72. doi: 10.1016/j.virol.2012.04.015. Epub 2012 May 16. Virology. 2012. PMID: 22595444
-
Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.PLoS One. 2011;6(11):e27953. doi: 10.1371/journal.pone.0027953. Epub 2011 Nov 30. PLoS One. 2011. PMID: 22140491 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical